Who owns the IP
The organizations most actively patenting around this compound, ranked by referenced patent volume.
| # | Assignee | Patents |
|---|---|---|
| 1 | Boehringer Ingelheim International GmbH | 121 |
| 2 | Calcimedica Inc | 12 |
| 3 | Vertex Pharmaceuticals Inc | 10 |
| 4 | Boehringer Ingelheim Pharma GmbH and Co KG | 8 |
| 5 | Childrens Hospital of Philadelphia CHOP | 7 |
| 6 | Boehringer Ingelheim Pharmaceuticals Inc | 6 |
| 7 | University of California San Diego UCSD | 6 |
| 8 | Millennium Pharmaceuticals Inc | 5 |
| 9 | Labcorp Holdings Inc | 4 |
| 10 | University of California | 4 |
Explore the full landscape
This preview shows the leading assignees. Cypris reveals the full ownership landscape - every filing entity, filing trends, and portfolio momentum.
Visit CyprisWhere innovation is concentrated
Patent classifications ranked by volume reveal the technical domains with the most active filing.
| # | Code | Area | Patents |
|---|---|---|---|
| 1 | A61P | Therapeutic activity (drug indications) | 243 |
| 2 | C07D | Heterocyclic compounds | 213 |
| 3 | A61K | Medicinal preparations | 151 |
| 4 | G01N | Investigating / analysing materials | 60 |
| 5 | Y02A | Climate change adaptation | 43 |
| 6 | G16B | 17 | |
| 7 | C07K | Peptides | 16 |
| 8 | C12Q | Measuring/testing involving enzymes | 13 |
| 9 | C07J | 10 | |
| 10 | G16C | 10 |
AI mapped opportunity space
This preview shows where patent activity concentrates. Cypris maps the full classification landscape to surface technical whitespace and IP headroom.
See Cypris in actionWhere research is gaining momentum
Research themes ranked by publication activity show where scientific interest is accelerating around this compound.
| # | Research topic | Papers |
|---|---|---|
| 1 | Drug Transport and Resistance Mechanisms | 2 |
Who's driving the science
The most-published authors working with this compound, alongside their primary affiliations.
| # | Author | Affiliation | Papers |
|---|---|---|---|
| 1 | Alexei V. Tepikin | University of Liverpool | 10 |
| 2 | Robert Sutton | University of Liverpool | 7 |
| 3 | David N. Criddle | University of Liverpool | 6 |
| 4 | Dieter Häussinger | Heinrich Heine University Düsseldorf | 6 |
| 5 | Ole H. Petersen | University of Liverpool | 6 |
| 6 | Oleg V. Gerasimenko | University of Liverpool | 5 |
| 7 | Roland Reinehr | Heinrich Heine University Düsseldorf | 5 |
| 8 | Sohail Z. Husain | University of Pittsburgh | 5 |
| 9 | Svetlana Voronina | University of Liverpool | 5 |
| 10 | Abrahim I. Orabi | University of Pittsburgh Medical Center | 4 |
Research leaders
This preview lists the top authors. Cypris surfaces the full researcher landscape, their affiliations, and how scientific influence is shifting.
See Cypris in actionThe literature that defines it
The most-cited papers anchoring the scientific record for this compound.
| Title | Year | Cited by | Topic |
|---|---|---|---|
| TLR9 and the NLRP3 Inflammasome Link Acinar Cell Death With Inflammation in Acute Pancreatitis | 2011 | 293 | Pancreatitis Pathology and Treatment |
| Biliary Acute Pancreatitis in Mice is Mediated by the G-Protein−Coupled Cell Surface Bile Acid Receptor Gpbar1 | 2009 | 123 | Protein Kinase Regulation and GTPase Signaling |
| Experimental acute biliary pancreatitis induced by retrograde infusion of bile acids into the mouse pancreatic duct | 2010 | 110 | Liver Disease Diagnosis and Treatment |
| Taurolithocholic acid-3 sulfate induces CD95 trafficking and apoptosis in a c-Jun N-terminal kinase–dependent manner | 2002 | 96 | Cell death mechanisms and regulation |
| Prevention of bile acid-induced apoptosis by betaine in rat liver | 2002 | 84 | Liver Disease Diagnosis and Treatment |
Frequently asked questions
Common questions about this compound's patent and research landscape, answered from the underlying data.
What is the molecular formula and weight of Sulfolithocholyltaurine?
Which organizations hold the most patents related to Sulfolithocholyltaurine?
What are the primary research topics associated with Sulfolithocholyltaurine?
Who are the leading researchers publishing on Sulfolithocholyltaurine?
What patent classification areas dominate the Sulfolithocholyltaurine patent landscape?